SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Drug Royalty Corporation (DRI-TSE) -- Ignore unavailable to you. Want to Upgrade?


To: BioInv who wrote (75)1/19/1999 6:32:00 PM
From: philip trigiani  Read Replies (1) | Respond to of 96
 
Because it is priced under $5.00, not too many institutionals will buy. But, it does have some analysts following. DRI is becoming a cash cow with all these on stream royalties. DRI is basicly trading at book value + cashflow/share.